# Exosomal circ_0093708 as a potential ferroptosis biomarker in cerebral ischemia–reperfusion injury

**Authors:** Shuyin Ma, Xiaodong Zhang, Jiaxin Fan, Mengying Chen, Qingling Yao, Nan Zhang, Kaili Shi, Shuang Du, Yuxuan Cheng, Huiyang Qu, Minyu Duan, Han Yang, Tiantian Gao, Shuqin Zhan

PMC · DOI: 10.3389/fneur.2025.1633393 · Frontiers in Neurology · 2025-08-01

## TL;DR

This study identifies exosomal circ_0093708 as a potential biomarker for ferroptosis in cerebral ischemia–reperfusion injury, offering new diagnostic and therapeutic insights.

## Contribution

The study introduces exosomal circ_0093708 as a novel ferroptosis biomarker in cerebral ischemia–reperfusion injury.

## Key findings

- Exosomal circ_0093708 shows high diagnostic accuracy (AUC = 0.93) for ferroptosis in cerebral ischemia–reperfusion injury.
- DUSP1 is upregulated during ferroptosis and its inhibition aggravates the condition.
- Circ_0093708 interacts with miR-101-3p and DUSP1, suggesting a regulatory role in ferroptosis.

## Abstract

Ferroptosis plays a critical role in neuronal injury following cerebral infarction. However, effective therapeutic strategies targeting ferroptosis after cerebral ischemia–reperfusion injury (CI/RI) remain limited. Exosome-based therapy holds significant promise in this context. This study aims to identify key exosomal markers of ferroptosis.

By integrating and analyzing multiple GSE datasets, we identified ferroptosis-associated key genes. These findings were further validated in external databases, cellular models, and animal experiments using malondialdehyde (MDA), glutathione (GSH), iron, reactive oxygen species (ROS) assays, qRT-PCR, Western blotting. By further establishing a ferroptosis model and inhibiting DUSP1 with drugs, we further explored the potential function of DUSP1 in ferroptosis. The role of miR-101-3p was assessed in CI/RI models, while the diagnostic value of exosomal circular RNA was evaluated using receiver operating characteristic curve analysis.

Combined differential analysis revealed PTGS2 and DUSP1 as ferroptosis-associated genes potentially regulated by exosomal circRNAs. In cellular and animal models, ferroptosis post-CI/RI was confirmed by elevated MDA, iron, and ROS levels, alongside reduced GSH. DUSP1 expression was significantly upregulated during ferroptosis, as demonstrated by qRT-PCR, Western blotting, and immunofluorescence. In the simple ferroptosis model, the expression of DUSP1 increases and inhibiting DUSP1 can aggravate ferroptosis. Conversely, miR-101-3p was downregulated in CI/RI, consistent with database predictions. Notably, exosomal circ_0093708 exhibited high diagnostic accuracy (Area under the curve = 0.93, sensitivity = 90%, specificity = 90%). Bioinformatics analysis suggested binding interactions among circ_0093708, miR-101-3p, and DUSP1.

Exosomal circ_0093708 is linked to DUSP1 and PTGS2 expression by sponging miR-101-3p, positioning it as a potential biomarker for ferroptosis in CI/RI.

## Linked entities

- **Genes:** DUSP1 (dual specificity phosphatase 1) [NCBI Gene 1843], PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743]
- **Chemicals:** malondialdehyde (PubChem CID 10964), glutathione (PubChem CID 124886), iron (PubChem CID 23925)

## Full-text entities

- **Genes:** PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, DUSP1 (dual specificity phosphatase 1) [NCBI Gene 1843] {aka CL100, HVH1, MKP-1, MKP1, PTPN10}
- **Diseases:** cerebral infarction (MESH:D002544), RI (MESH:C564256), cerebral ischemia-reperfusion injury (MESH:D015427), neuronal injury (MESH:D009410)
- **Chemicals:** MDA (MESH:D008315), ROS (MESH:D017382), GSH (MESH:D005978), iron (MESH:D007501)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12354519/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12354519/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12354519/full.md

---
Source: https://tomesphere.com/paper/PMC12354519